Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor entity, characterized by rapid disease progression, early metastatic dissemination, and late diagnosis at advanced tumor stages. Recently, we explored the clinical impact of several microRNAs (miR) associated with proliferation, epi...
Main Authors: | Moritz Reese, Isabelle Flammang, Zixuan Yang, Sameer A. Dhayat |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/1/197 |
Similar Items
-
Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma
by: Isabelle Flammang, et al.
Published: (2020-06-01) -
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
by: Sameer Abdallah Dhayat, et al.
Published: (2018-09-01) -
Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma
by: Jiayi Wang, et al.
Published: (2023-07-01) -
The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
by: Sheng-Kai Hsu, et al.
Published: (2023-03-01) -
Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
by: Daniel C. Osei-Bordom, et al.
Published: (2022-01-01)